Ohio Public Employees Retirement System (OPERS)’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$561K Buy
38,501
+4,502
+13% +$79.8K ﹤0.01% 1467
2026
Q1
$645K Sell
33,999
-1,159
-3% -$18.7K ﹤0.01% 1417
2025
Q4
$615K Sell
35,158
-1,334
-4% -$25.1K ﹤0.01% 1457
2025
Q3
$754K Buy
36,492
+227
+0.6% +$5.5K ﹤0.01% 1425
2025
Q2
$772K Buy
+36,265
New +$827K ﹤0.01% 1408

Other funds holding SMMT

Ohio Public Employees Retirement System (OPERS)'s SMMT Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Summit Therapeutics (SMMT) stake by 13% in Q2 2026, buying an estimated $79.8K and bringing the position to 38,501 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

Ohio Public Employees Retirement System (OPERS) first reported a position in SMMT in Q2 2025 and has held it in 5 quarters since. The position peaked at $772K in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 38,501 shares of Summit Therapeutics worth $561K as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) bought 4,502 Summit Therapeutics shares in Q2 2026, an estimated $79.8K.
  • Summit Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1467 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Summit Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Summit Therapeutics position peaked at $772K in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.